Please assess the completion status of the following clinical trial:

Trial Title: Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 18+~* Patients diagnosed with obesity hypoventilation syndrome (OHS) and/or obstructive sleep apnea (OSA) by a practicing sleep or respiratory physician, requiring positive airway pressure (PAP) therapy~Exclusion Criteria:~* Recent cardiac or respiratory arrest~* Gastro intestinal bleeding, ileus or recent gastrointestinal surgery~* Coma, decreased level of consciousness or agitation~* Anatomical or subjective difficulty with airway access e.g. facial surgery, trauma, vomiting upper airway obstruction~* Cerebrospinal fluid leak, abnormalities of the cribiform plate or prior history of head trauma.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Positive airway pressure (PAP) device (Type: EXPERIMENTAL): Fisher \& Paykel Healthcare PAP Device. Participants will sleep overnight using themodified positive airway pressure device. Their pressures will be titrated by a qualified sleep technician, they will then be optimised during the night.

Based on this trial design, predict the completion outcome and termination type (if applicable).